• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干眼病情进展(PROOF)自然史研究的研究设计与基线研究结果

Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.

作者信息

McDonnell Peter J, Pflugfelder Stephen C, Stern Michael E, Hardten David R, Conway Taryn, Villanueva Linda, Hollander David A

机构信息

Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Maumenee 727, Baltimore, MD, 21287-0005, USA.

Baylor Eye Physicians & Surgeons Houston, 6565 Fannin NC 205, Houston, TX, 77030, USA.

出版信息

BMC Ophthalmol. 2017 Dec 28;17(1):265. doi: 10.1186/s12886-017-0646-5.

DOI:10.1186/s12886-017-0646-5
PMID:29284427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5746001/
Abstract

BACKGROUND

The aim of this research is to initiate a 5-year natural history study of dry eye disease (DED) using objectively assessed and patient-reported outcomes, to explore the hypothesis that DED is a progressive condition that has substantive and measurable impacts not only on the ocular surface, but on quality of life and visual functioning. Our objective for this report is to examine the baseline data.

METHODS

A multicenter, prospective, controlled, observational study of Level 2 (mild-to-moderate) DED patients based on International Task Force Delphi Panel severity grading, and controls, documented baseline measures (including tear film biomarkers and quality of life). Tear cytokine concentrations were also measured in the tear film. Patients were using artificial tears as needed.

RESULTS

Two hundred seventeen DED patients and 67 gender- and age-matched controls were enrolled. A majority were females and Caucasian and groups did not differ significantly in terms of gender, race, or age. Differences between DED and matched controls, at baseline, included mean scores for Ocular Surface Disease Index (31.7 vs 4.1, P < 0.0001), Schirmer test (5.7 vs 15.3 mm, P < 0.0001), corneal staining (1.4 vs 0.2, P < 0.0001), conjunctival staining (1.4 vs 0.3, P < 0.0001), and tear break-up time (5.7 vs 8.5 s, P < 0.0001). Tear cytokines levels were determined and included interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, tumor necrosis factor-α, epidermal growth factor, IL-13, IL-17, IL-1α, and inducible protein-10. The mean levels of IL-8 and IL-6 were slightly higher in the DED group at baseline. Blurred vision was reported as moderate/severe/very severe at baseline in 57.6% of DED patients vs.10.5% of normal controls (P < 0.0001). DED patients reported greater reductions in work and non-work productivity, as well as greater need for visits to ophthalmologists during the prior year.

CONCLUSIONS

In this report of the baseline findings of a 5-year natural history study of DED, a striking disease burden is observed with regard to blurred vision, productivity, and visits to eye care practitioners in mild to moderate DED patients compared to normal subjects of similar ages and genders.

TRIAL REGISTRATION

ClinicalTrials.gov NCT00833235 on January 30, 2009.

摘要

背景

本研究旨在开展一项为期5年的干眼症(DED)自然史研究,采用客观评估和患者报告的结果,以探讨DED是一种进行性疾病这一假说,该疾病不仅对眼表有实质性和可测量的影响,还对生活质量和视觉功能有影响。本报告的目的是检查基线数据。

方法

一项基于国际任务组德尔菲专家组严重程度分级的多中心、前瞻性、对照、观察性研究,纳入2级(轻度至中度)DED患者及对照,记录基线指标(包括泪膜生物标志物和生活质量)。还测量了泪膜中的泪液细胞因子浓度。患者根据需要使用人工泪液。

结果

共纳入217例DED患者和67例年龄及性别匹配的对照。大多数为女性和白种人,两组在性别、种族或年龄方面无显著差异。DED组与匹配对照组在基线时的差异包括眼表疾病指数平均得分(31.7对4.1,P<0.0001)、泪液分泌试验(5.7对15.3mm,P<0.0001)、角膜染色(1.4对0.2,P<0.0001)、结膜染色(1.4对0.3,P<0.0001)以及泪膜破裂时间(5.7对8.5秒,P<0.0001)。测定了泪液细胞因子水平,包括干扰素-γ、白细胞介素(IL)-1β、IL-2、IL-4、IL-6、IL-8、肿瘤坏死因子-α、表皮生长因子、IL-13、IL-17、IL-1α和诱导蛋白-10。DED组基线时IL-8和IL-6的平均水平略高。57.6%的DED患者在基线时报告视力模糊为中度/重度/极重度,而正常对照组为10.5%(P<0.0001)。DED患者报告在前一年工作和非工作生产力下降更多,以及看眼科医生的需求更大。

结论

在本项关于DED为期5年自然史研究的基线结果报告中,与年龄和性别相似的正常受试者相比,轻度至中度DED患者在视力模糊、生产力和看眼科医生方面存在明显的疾病负担。

试验注册

ClinicalTrials.gov NCT00833235,于2009年1月30日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222b/5746001/52be29882278/12886_2017_646_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222b/5746001/52be29882278/12886_2017_646_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/222b/5746001/52be29882278/12886_2017_646_Fig1_HTML.jpg

相似文献

1
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.干眼病情进展(PROOF)自然史研究的研究设计与基线研究结果
BMC Ophthalmol. 2017 Dec 28;17(1):265. doi: 10.1186/s12886-017-0646-5.
2
Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.干眼症疾病临床严重程度与泪液细胞因子、趋化因子和可溶性受体的相关性。
Invest Ophthalmol Vis Sci. 2012 Aug 13;53(9):5443-50. doi: 10.1167/iovs.11-9417.
3
The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.良性特发性眼睑痉挛对干眼症和眼表炎症的影响。
Am J Ophthalmol. 2014 Mar;157(3):591-7.e1-2. doi: 10.1016/j.ajo.2013.11.014. Epub 2013 Nov 20.
4
A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.感染人类免疫缺陷病毒(HIV)的干眼症(DED)患者泪膜中独特的细胞因子谱。
Cytokine. 2016 Dec;88:77-84. doi: 10.1016/j.cyto.2016.08.026. Epub 2016 Aug 29.
5
Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.干眼评估和管理研究中与干眼体征和症状严重程度相关的系统性疾病。
Ophthalmology. 2021 Oct;128(10):1384-1392. doi: 10.1016/j.ophtha.2021.03.030. Epub 2021 Mar 27.
6
The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.使用结膜染色法测量干眼症患者的眼表炎症
Cornea. 2019 Jun;38(6):698-705. doi: 10.1097/ICO.0000000000001916.
7
Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.泪液细胞因子比值与干眼疾病症状和体征的相关性:干眼评估和管理研究的生物标志物数据。
Curr Eye Res. 2024 Jan;49(1):16-24. doi: 10.1080/02713683.2023.2262168. Epub 2024 Jan 3.
8
Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.A型肉毒杆菌毒素对干眼症及泪液细胞因子的治疗作用
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):331-338. doi: 10.1007/s00417-018-4194-3. Epub 2018 Dec 14.
9
Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?干眼症的最佳人工泪液治疗能否根据临床表现和症状预测?
Cont Lens Anterior Eye. 2018 Feb;41(1):60-68. doi: 10.1016/j.clae.2017.07.007. Epub 2017 Aug 12.
10
Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.使用市售即时免疫检测法在干燥性眼病中检测基质金属蛋白酶 9。
Ophthalmology. 2016 Nov;123(11):2300-2308. doi: 10.1016/j.ophtha.2016.07.028. Epub 2016 Sep 21.

引用本文的文献

1
Diagnostic methods for managing dry eyes.干眼症的诊断方法。
World J Methodol. 2025 Dec 20;15(4):101033. doi: 10.5662/wjm.v15.i4.101033.
2
Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study.全氟己基辛烷眼药水对干眼病患者报告结局的早期影响:一项前瞻性、开放标签、多中心研究
Ophthalmol Ther. 2025 Apr;14(4):693-704. doi: 10.1007/s40123-025-01097-z. Epub 2025 Feb 22.
3
Multicomponent Dietary Supplementation: Impact on Tear Secretion and Ocular Surface Inflammation in Dry Eye Syndrome Patients.

本文引用的文献

1
Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.泪液干扰素-γ作为蒸发型干眼疾病的生物标志物
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4824-4830. doi: 10.1167/iovs.16-19757.
2
Mechanisms of Visual Disturbance in Dry Eye.干眼视觉障碍的机制
Cornea. 2016 Nov;35 Suppl 1:S83-S88. doi: 10.1097/ICO.0000000000000998.
3
Functional impairment of reading in patients with dry eye.干眼症患者的阅读功能障碍
多成分膳食补充剂:对干眼症患者泪液分泌及眼表炎症的影响
Antioxidants (Basel). 2025 Jan 16;14(1):103. doi: 10.3390/antiox14010103.
4
Dry eye module - An application intelligence platform for diagnosing and monitoring dry eye disease.干眼模块-用于诊断和监测干眼疾病的应用智能平台。
Indian J Ophthalmol. 2023 Apr;71(4):1407-1412. doi: 10.4103/IJO.IJO_2810_22.
5
Tear biomarkers in dry eye disease: Progress in the last decade.干眼疾病的泪液生物标志物:过去十年的进展。
Indian J Ophthalmol. 2023 Apr;71(4):1190-1202. doi: 10.4103/IJO.IJO_2981_22.
6
Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.泪液细胞因子浓度与干眼疾病症状和体征的相关性:干眼评估和管理(DREAM)研究的基线数据。
Curr Eye Res. 2023 Apr;48(4):339-347. doi: 10.1080/02713683.2022.2162088. Epub 2023 Jan 11.
7
Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.在一个纵向、三级诊所样本中,干燥综合征与非干燥综合征相关的干眼症的结果。
PLoS One. 2021 Dec 17;16(12):e0261241. doi: 10.1371/journal.pone.0261241. eCollection 2021.
8
Work productivity among Sjögren's Syndrome and non-Sjögren's dry eye patients: a systematic review and meta-analysis.干燥综合征和非干燥综合征干眼患者的工作生产力:系统评价和荟萃分析。
Eye (Lond). 2021 Dec;35(12):3243-3257. doi: 10.1038/s41433-020-01282-3. Epub 2021 Jan 21.
9
A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease.一项评估新型 RASP 抑制剂滴眼用 reproxalap 治疗干眼症的活性和安全性的随机、双盲、2a 期临床试验
J Ocul Pharmacol Ther. 2021 May;37(4):193-199. doi: 10.1089/jop.2020.0087. Epub 2021 Jan 15.
10
The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis.IL-6-174 G/C 多态性和眼内 IL-6 水平在眼病发病机制中的作用:系统评价和荟萃分析。
Sci Rep. 2020 Oct 15;10(1):17453. doi: 10.1038/s41598-020-74203-9.
Br J Ophthalmol. 2017 Apr;101(4):481-486. doi: 10.1136/bjophthalmol-2015-308237. Epub 2016 Jul 22.
4
Long-term Natural History of Dry Eye Disease from the Patient's Perspective.从患者角度看干眼症的长期自然史
Ophthalmology. 2016 Feb;123(2):425-433. doi: 10.1016/j.ophtha.2015.10.011. Epub 2015 Nov 21.
5
Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients.环孢素滴眼液治疗干眼症患者的治疗模式的健康声明数据库研究。
Ther Clin Risk Manag. 2013;9:409-15. doi: 10.2147/TCRM.S49754. Epub 2013 Oct 25.
6
Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.分析干燥综合征干眼患者和非干燥综合征干眼患者的泪液细胞因子与临床相关性。
Am J Ophthalmol. 2013 Aug;156(2):247-253.e1. doi: 10.1016/j.ajo.2013.04.003. Epub 2013 Jun 7.
7
Dry eye as a mucosal autoimmune disease.干眼症作为一种黏膜自身免疫性疾病。
Int Rev Immunol. 2013 Feb;32(1):19-41. doi: 10.3109/08830185.2012.748052.
8
Evaluation of reading speed and contrast sensitivity in dry eye disease.干眼症患者阅读速度与对比敏感度的评估
Optom Vis Sci. 2013 Jan;90(1):37-44. doi: 10.1097/OPX.0b013e3182780dbb.
9
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.眼表面免疫:干眼症中稳态机制及其破坏。
Prog Retin Eye Res. 2012 May;31(3):271-85. doi: 10.1016/j.preteyeres.2012.02.003. Epub 2012 Mar 8.
10
A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry.一种从干燥综合征国际登记处评估干燥性角结膜炎的简化定量方法。
Am J Ophthalmol. 2010 Mar;149(3):405-15. doi: 10.1016/j.ajo.2009.09.013. Epub 2009 Dec 29.